SIGA Technologies バランスシートの健全性
財務の健全性 基準チェック /66
SIGA Technologiesの総株主資本は$169.4M 、総負債は$0.0で、負債比率は0%となります。総資産と総負債はそれぞれ$195.4Mと$25.9Mです。 SIGA Technologiesの EBIT は$104.6Mで、利息カバレッジ比率-25.2です。現金および短期投資は$99.3Mです。
主要情報
0%
負債資本比率
US$0
負債
| インタレスト・カバレッジ・レシオ | -25.2x |
| 現金 | US$99.27m |
| エクイティ | US$169.44m |
| 負債合計 | US$25.91m |
| 総資産 | US$195.35m |
財務の健全性に関する最新情報
更新なし
Recent updates
SIGA Technologies: Expansion Into mAbs Is Smart, But Eggs Remain In One Basket
Nov 21Investors Shouldn't Be Too Comfortable With SIGA Technologies' (NASDAQ:SIGA) Earnings
Nov 15
SIGA Technologies, Inc. (NASDAQ:SIGA) Not Doing Enough For Some Investors As Its Shares Slump 34%
Sep 14SIGA Technologies: Shares Tanking On Mpox Study Miss, Turbulence May Be Temporary
Aug 15SIGA Technologies, Inc. (NASDAQ:SIGA) Held Back By Insufficient Growth Even After Shares Climb 31%
Jul 14SIGA Technologies: BARDA Contract Renewal Required To Sustain Recent Momentum (Rating Downgrade)
Jun 13SIGA Technologies, Inc. (NASDAQ:SIGA) Stock Rockets 64% But Many Are Still Ignoring The Company
Mar 31Siga Technologies: Preparing For A Contingency If Tomorrow Comes
Mar 25Shareholders Can Be Confident That SIGA Technologies' (NASDAQ:SIGA) Earnings Are High Quality
Mar 19The Price Is Right For SIGA Technologies, Inc. (NASDAQ:SIGA)
Feb 15Do SIGA Technologies' (NASDAQ:SIGA) Earnings Warrant Your Attention?
Jan 13SIGA Technologies secures new contract awarded to procure up to $10.7M of TPOXX
Sep 29Siga monkeypox therapy undergoes NIH-led late-stage trial
Sep 09Scientists behind key COVID study run monkeypox trial for SIGA therapy
Aug 23SIGA to activate first trial sites for monkeypox therapy in U.K. next week – Bloomberg
Aug 17Estimating The Fair Value Of SIGA Technologies, Inc. (NASDAQ:SIGA)
Aug 12SIGA to deliver $26M of monkeypox therapy to U.S. in 2023 after option exercise
Aug 09SIGA Technologies: Unjustified Selloff, Loading The Boat, Best Monkeypox Play
Aug 01SIGA Technologies: Buy Monkeypox
Jul 25Siga Technologies receives approval from UK for tecovirimat
Jul 08SIGA Technologies: Solid Business With Means To Address Monkeypox Outbreak
May 27SIGA Technologies: There's An Assured Market For A Smallpox Vaccine
Dec 12It's Probably Less Likely That SIGA Technologies, Inc.'s (NASDAQ:SIGA) CEO Will See A Huge Pay Rise This Year
Jun 08SIGA Technologies: Biodefense Pharma Unlocks New Value Abroad For TPOXX
Apr 28Introducing SIGA Technologies (NASDAQ:SIGA), The Stock That Soared 880% In The Last Five Years
Feb 22財務状況分析
短期負債: SIGAの 短期資産 ( $180.7M ) が 短期負債 ( $22.3M ) を超えています。
長期負債: SIGAの短期資産 ( $180.7M ) が 長期負債 ( $3.6M ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: SIGAは負債がありません。
負債の削減: SIGA負債比率が76.7%であった 5 年前と比べて負債がありません。
債務返済能力: SIGAには負債がないため、営業キャッシュフロー でカバーする必要はありません。
インタレストカバレッジ: SIGAには負債がないため、利息支払い の負担は問題になりません。